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Background
Genetic differences may contribute to the inter-indivi-
dual differences in treatment response to antidepres-
sants among patients suffering from major depression.
This study investigated a possible association of various
monoamine transporter genetic polymorphisms with
treatment response to mirtazapine in major depressive
patients in elderly.
Materials and methods
In this study, three genetic polymorphisms were
selected: serotonin transporter 5-HTTLPR, serotonin
transporter 5-HTT intron 2 VNTR, and norepinephrine
transporter NET(G1287A). The patients with major
depression diagnosed by DSM-IV were recruited to a
6-week naturalistic mirtazapine treatment study in Sam-
sung Medical Center. Treatment response to mirtaza-
pine was defined as ≥50% decrease in HAMD-17 scores
at 6 weeks, and the genotypes in the patients were
determined using the polymerase chain reaction.
Results
Our results showed that ss allele carriers were included
more in responder group(ss allele in responder vs. non
responder group; 69.4% vs. 40.0%). In addition, l-allele
(sl/ll) carriers were included less in responder group(sl/ll
allele in responder vs. non responder group; 30.6% vs.
60.0%). Multiple logistic regression analyses showed the
5-HTTLPR polymorphism as an predictor of the
mirtazapine response (5HTTLPR ss allele carrier vs.
l-allele (sl/ll) carrier; odds ratio: 3.81; 95% confidence
interval [CI], 1.32-11.0; P = 0.013). However, 5-HTT
intron 2 VNTR l/s (P = 0.33 by multiple logistic regres-
sion; [OR], 0.53; 95% [CI], 0.15-1.88), and NET
(G1287A) G/A (P = 0.68 by multiple logistic regression;
[OR], 1.25; 95% [CI], 0.44-3.53) showed no statistical
significant influences on response rate.
Conclusions
In conclusion, 5HTTLPR polymorphism may predict
treatment response to mirtazapine in major depressive
patients in elderly.
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